NeoImmuneTech (XKRX:950220) Other Long Term Assets : ₩4,338.06 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Other Long Term Assets?

NeoImmuneTech's other long-term assets for the quarter that ended in Dec. 2023 was ₩4,338.06 Mil.

NeoImmuneTech's quarterly other long-term assets declined from Jun. 2023 (₩6,017.70 Mil) to Sep. 2023 (₩5,878.42 Mil) but then stayed the same from Sep. 2023 (₩5,878.42 Mil) to Dec. 2023 (₩4,338.06 Mil).

NeoImmuneTech's annual other long-term assets increased from Dec. 2021 (₩4,658.72 Mil) to Dec. 2022 (₩5,943.87 Mil) but then declined from Dec. 2022 (₩5,943.87 Mil) to Dec. 2023 (₩4,338.06 Mil).

NeoImmuneTech Other Long Term Assets Historical Data

The historical data trend for NeoImmuneTech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoImmuneTech Other Long Term Assets Chart

NeoImmuneTech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

1,158.71

4,484.02

4,658.72

5,943.87

4,338.06

NeoImmuneTech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial											5,943.87	6,953.25	6,017.70	5,878.42	4,338.06

NeoImmuneTech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

NeoImmuneTech (XKRX:950220) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850

Website

http://www.neoimmunetech.com

NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.

NeoImmuneTech (XKRX:950220) Headlines

No Headlines